These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6157754)
1. Elevated levels of antibodies to polyuridylic acid detected and quantitated in systemic scleroderma patients by solid phase radioimmunoassay. Heinzerling RH; Weyer R; Dziuba DS; Belviso HM; Burnham TK J Invest Dermatol; 1980 Sep; 75(3):224-7. PubMed ID: 6157754 [TBL] [Abstract][Full Text] [Related]
2. Significance of levels of specific immunoglobulins to DNA in SLE patients' sera detected by solid phase radioimmunoassay. Heinzerling RH; Dziuba DS; Federyszyn HM; Burnham TK J Invest Dermatol; 1979 Feb; 72(2):55-8. PubMed ID: 422867 [TBL] [Abstract][Full Text] [Related]
3. Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. II. Reactivity with hsa-coupled, uridine-containing, monophosphoric ribodinucleotides. Alarcón-Segovia D; Fishbein E; Estrada-Parra S; García-Ortigoza E Immunology; 1976 Mar; 30(3):413-8. PubMed ID: 1082854 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus. Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075 [TBL] [Abstract][Full Text] [Related]
5. Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. I. Differences in reactivity with Poly (U) and Poly-(A) Poly (U). Alarcón-Segovia D; Fishbein E J Immunol; 1975 Jul; 115(1):28-31. PubMed ID: 50353 [TBL] [Abstract][Full Text] [Related]
6. Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children. Hanson V; Kornreich HK; Drexler E; Johnson GD; Macpherson GA Pediatr Res; 1974 Sep; 8(9):806-9. PubMed ID: 4213387 [No Abstract] [Full Text] [Related]
7. Soluble CD4 and CD8 in serum from patients with localized scleroderma. Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K Arch Dermatol Res; 1996 Jun; 288(7):358-62. PubMed ID: 8818182 [TBL] [Abstract][Full Text] [Related]
9. High titers of antibodies to single-stranded DNA in linear scleroderma. Falanga V; Medsger TA; Reichlin M Arch Dermatol; 1985 Mar; 121(3):345-7. PubMed ID: 3883904 [TBL] [Abstract][Full Text] [Related]
10. Immunohistological studies, with anti-connective tissue and anti-immunoglobulin antisera, of the skin in lupus erythematosus and scleroderma. Rowell NR; Scott DG Br J Dermatol; 1975 Oct; 93(4):431-41. PubMed ID: 1081402 [TBL] [Abstract][Full Text] [Related]
11. [Use of I125 labelled poly(I). poly(C) for determination of antibodies to double-stranded RNA by immune complex absorption to nitrocellulose filters]. Pedgorodnichenko VK; Tsypliakovskaia LM; Karpov VL; Nasonova VA; Poverennyĭ AM Mol Biol (Mosk); 1976; 10(2):314-20. PubMed ID: 1084953 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin 1, in patients with localized scleroderma. Arnett FC; Tan FK; Uziel Y; Laxer RM; Krafchik BR; Antohi S; Bona C Arthritis Rheum; 1999 Dec; 42(12):2656-9. PubMed ID: 10616014 [TBL] [Abstract][Full Text] [Related]
13. Antinucleosome antibody is a major autoantibody in localized scleroderma. Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513 [TBL] [Abstract][Full Text] [Related]
14. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [TBL] [Abstract][Full Text] [Related]
16. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103 [TBL] [Abstract][Full Text] [Related]
17. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Falanga V; Medsger TA; Reichlin M Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090 [TBL] [Abstract][Full Text] [Related]
18. Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Hoffman RW; Sharp GC; Irvin WS; Anderson SK; Hewett JE; Pandey JP Arthritis Rheum; 1991 Apr; 34(4):453-8. PubMed ID: 1826425 [TBL] [Abstract][Full Text] [Related]
19. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma. Ihn H; Fujimoto M; Sato S; Kikuchi K; Igarashi A; Soma Y; Takehara K J Am Acad Dermatol; 1994 Oct; 31(4):591-5. PubMed ID: 7916356 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against RNA polymerase I in scleroderma and Sjögren's syndrome sera. Stetler DA; Reichlin M; Berlin CM; Jacob ST Biochem Biophys Res Commun; 1987 May; 144(3):1296-302. PubMed ID: 3579959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]